BUZZ-ClearPoint Neuro adds to gains, up 125% since Sept 23

Reuters

Oct 04

BUZZ-<a href="https://laohu8.com/S/CLPT">ClearPoint Neuro</a> adds to gains, up 125% since Sept 23

** The stock of device and technology company ClearPoint Neuro CLPT.O is up 10% on Friday to $27.40, the highest since February 2021. It has risen 125% since September 23

** The stock jumped after uniQure N.V. QURE.O said before the bell on September 24 that it completed a successful trial of its gene therapy for Huntington's disease. ClearPoint Neuro provides the device for the Dutch biotech firm's gene therapy

** ClearPoint announcedon October 1 the development and demonstration of its proprietary Robotic Neuro-Navigation System

** Lake Street Capital Markets and B. Riley Securities both have a 'buy' rating on CLPT, with a $30 and $28 price target, respectively

** California-based ClearPoint has nearly $800 mln current market cap

(Reporting by Karen Brettell)

((karen.brettell@tr.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2572035689"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2572035689\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2572035689?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-04 00:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2572035689","market":"us","top_or_hot":-1,"title":"BUZZ-ClearPoint Neuro adds to gains, up 125% since Sept 23","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/CLPT\">ClearPoint Neuro</a> adds to gains, up 125% since Sept 23</title></head><body><p>** The stock of device and technology company ClearPoint Neuro <span>CLPT.O</span> is up 10% on Friday to $27.40, the highest since February 2021. It has risen 125% since September 23</p><p>** The stock jumped after <a href=\"https://laohu8.com/S/QURE\">uniQure N.V.</a> <span>QURE.O</span> said before the bell on September 24 that it completed a <span>successful trial</span> of its gene therapy for Huntington's disease. ClearPoint Neuro provides the device for the Dutch biotech firm's gene therapy</p><p>** ClearPoint announcedon October 1 the development and demonstration of its proprietary Robotic Neuro-Navigation System</p><p>** Lake Street Capital Markets and <a href=\"https://laohu8.com/S/RILY\">B. Riley</a> Securities both have a 'buy' rating on CLPT, with a $30 and $28 price target, respectively</p><p>** California-based ClearPoint has nearly $800 mln current market cap</p><p>(Reporting by Karen Brettell)</p><p>((karen.brettell@tr.com))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-ClearPoint Neuro adds to gains, up 125% since Sept 23</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-ClearPoint Neuro adds to gains, up 125% since Sept 23\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-04 00:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/CLPT\">ClearPoint Neuro</a> adds to gains, up 125% since Sept 23</title></head><body><p>** The stock of device and technology company ClearPoint Neuro <span>CLPT.O</span> is up 10% on Friday to $27.40, the highest since February 2021. It has risen 125% since September 23</p><p>** The stock jumped after <a href=\"https://laohu8.com/S/QURE\">uniQure N.V.</a> <span>QURE.O</span> said before the bell on September 24 that it completed a <span>successful trial</span> of its gene therapy for Huntington's disease. ClearPoint Neuro provides the device for the Dutch biotech firm's gene therapy</p><p>** ClearPoint announcedon October 1 the development and demonstration of its proprietary Robotic Neuro-Navigation System</p><p>** Lake Street Capital Markets and <a href=\"https://laohu8.com/S/RILY\">B. Riley</a> Securities both have a 'buy' rating on CLPT, with a $30 and $28 price target, respectively</p><p>** California-based ClearPoint has nearly $800 mln current market cap</p><p>(Reporting by Karen Brettell)</p><p>((karen.brettell@tr.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nL2N3VK0J8:1","article_id":"2572035689","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2572035689","pubTimestamp":1759507617,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-ClearPoint Neuro adds to gains, up 125% since Sept 23** The stock of device and technology company ClearPoint Neuro CLPT.O is up 10% on Friday to $27.40, the highest since February 2021. It has risen 125% since September 23** The stock jumped after uniQure N.V. QURE.O said before the bell on September 24 that it completed a successful trial of its gene therapy for Huntington's disease. ClearPoint Neuro provides the device for the Dutch biotech firm's gene therapy** ClearPoint announcedon October 1 the development and demonstration of its proprietary Robotic Neuro-Navigation System** Lake Street Capital Markets and B. Riley Securities both have a 'buy' rating on CLPT, with a $30 and $28 price target, respectively** California-based ClearPoint has nearly $800 mln current market cap","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","CLPT":"ClearPoint Neuro, Inc."},"translate_title":"BUZZ-ClearPoint Neuro进一步上涨，自9月23日以来上涨125%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLPT":0.9},"content_text":"BUZZ-ClearPoint Neuro adds to gains, up 125% since Sept 23** The stock of device and technology company ClearPoint Neuro CLPT.O is up 10% on Friday to $27.40, the highest since February 2021. It has risen 125% since September 23** The stock jumped after uniQure N.V. QURE.O said before the bell on September 24 that it completed a successful trial of its gene therapy for Huntington's disease. ClearPoint Neuro provides the device for the Dutch biotech firm's gene therapy** ClearPoint announcedon October 1 the development and demonstration of its proprietary Robotic Neuro-Navigation System** Lake Street Capital Markets and B. Riley Securities both have a 'buy' rating on CLPT, with a $30 and $28 price target, respectively** California-based ClearPoint has nearly $800 mln current market cap(Reporting by Karen Brettell)((karen.brettell@tr.com))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}